Abstract
Background
Obesity has been shown to be associated with reduced survival in patients with invasive breast cancer (IBC), although the mechanisms for this finding are unclear. The objective of this study was to examine the effect of obesity on the presentation and pathologic staging of IBC.
Methods
From February 15, 2002, to February 15, 2004, all patients undergoing surgery for primary IBC at two institutions were enrolled in a prospective cohort study. National Institutes of Health criteria were used to categorize patients: normal or underweight (NW; body mass index <25 kg/m2), overweight (OW; body mass index 25–29.9 kg/m2), and obese or severely obese (OB; body mass index ≥30 kg/m2). Presentation and pathologic factors were then compared among groups.
Results
The study cohort consisted of 519 patients; 166 (32%) were NW, 177 (34%) were OW, and 176 (34%) were OB. OW (46%) and OB (39%) patients were more likely to be diagnosed with IBC via screening mammography compared with NW (31%) patients (P = .01), although no differences were found between groups with respect to previous use of screening mammography. Aggressive pathologic features, including lymph node metastases, advanced tumor-node-metastasis stage, and grade were found more commonly among OB patients.
Conclusions
OW and OB patients were more likely to receive a diagnosis via screening mammography, thus suggesting that mammography may play a more important role in OW and OB patients. Despite this, OB patients presented with larger, more advanced tumors; this may help to explain obesity-associated survival differences in IBC patients. This is important information given the prevalence of obesity in North America.
Similar content being viewed by others
References
Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728–32
Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US adults, 1999-2000. JAMA 2002; 288:1723–7
Mokdad AH, Bowman BA, Fors ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 296:1195–200
International Agency for Research on Cancer. Weight Control and Physical Activity. Lyon, France: IARC Press, 2002
Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004; 159:259–68
Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast 2004; 13:85–92
Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995;6:137–41
Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997; 278:1407–11
Magnusson C, Baron J, Persson I, et al. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998; 76:29–34
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospective cohort of US adults. N Engl J Med 2003; 348:1625–38
Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer 2003; 45:1–16
Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press, 1989
Hosmer DW, Lemeshow S. Introduction to the logistic regression model. In: Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. Toronto: Wiley Press, 1989; 18–32
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289:187–93
Hunt KA, Sickles EA. Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. AJR Am J Roentgenol 2000; 174:1251–5
Elmore JG, Carney PA, Abraham LA, et al. The association between obesity and screening mammography accuracy. Arch Intern Med 2004; 164:1140–7
Hall HI, Coates RJ, Uhler RJ, et al. Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer 1999; 82:23–7
Maehle BO, Tretli S, Skjaerven R, Thorsen T. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesterone receptor status. Breast Cancer Res Treat 2001; 68:159–69
Cui Y, Whiteman MK, Flaws JA, et al. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002; 98:279–83
Daniell HW, Tam E, Filice A. Larger axillary metastases in obese women and smokers with breast cancer—an influence by host factors on early tumor behavior. Breast Cancer Res Treat 1993; 25:193–201
Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and body fat distribution and breast cancer prognosis. Cancer 1991; 67:523–8
Arndt V, Sturmer T, Stegmaier C, et al. Patient delay and stage of diagnosis among breast cancer patients in Germany—a population-based study. Br J Cancer 2002; 86:1034–40
Richardson JL, Langholz B, Bernstein L, et al. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 1992; 65:922–6
Richardson JL, Langholz B, Bernstein L, et al. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 1992; 65:922–6
Endogenous Hormones and Breast Cancer Collaborative Group. Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218–26
Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Geiger SR, Astwood EB, Greep RO, eds. Handbook of Physiology. Washington, DC: American Physiological Society, 1973; 615–29
Stoll BA. Obesity and breast cancer. Int J Obes Relat Metab Disord 1996; 20:389–92
Folsom AR, Kaye SA, Prineas RJ, et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131:794–803
Feigelson HS, Henderson BE. Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention. Breast Cancer Res 2000; 2:277–82
Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20:42–51
Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimes of hormone therapy and risk of breast cancer. JAMA 2003; 289:3254–63
Chen CL, Weiss NS, Newcombe P, et al. Hormone replacement therapy in relation to breast cancer. JAMA 2002; 287:734–41
Acknowledgments
The authors thank Janet Hartnett and John Fris for administrative assistance related to the manuscript. Supported by Nova Scotia Health Research Foundation grant 40561 and the Clinical Scholars program at Dalhousie University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Porter, G.A., Inglis, K.M., Wood, L.A. et al. Effect of Obesity on Presentation of Breast Cancer. Ann Surg Oncol 13, 327–332 (2006). https://doi.org/10.1245/ASO.2006.03.049
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.03.049